NO171147C - Fremgangsmaate for fremstilling av en vaksine mot hepatittb - Google Patents

Fremgangsmaate for fremstilling av en vaksine mot hepatittb

Info

Publication number
NO171147C
NO171147C NO875142A NO875142A NO171147C NO 171147 C NO171147 C NO 171147C NO 875142 A NO875142 A NO 875142A NO 875142 A NO875142 A NO 875142A NO 171147 C NO171147 C NO 171147C
Authority
NO
Norway
Prior art keywords
vaccine
hepatitis
zonal
subjected
procedure
Prior art date
Application number
NO875142A
Other languages
English (en)
Other versions
NO171147B (no
NO875142L (no
NO875142D0 (no
Inventor
Philippe Jean Adamowicz
Marie Noelle Mevelec
Marc Girard
Original Assignee
Pasteur Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins
Publication of NO875142D0 publication Critical patent/NO875142D0/no
Publication of NO875142L publication Critical patent/NO875142L/no
Publication of NO171147B publication Critical patent/NO171147B/no
Publication of NO171147C publication Critical patent/NO171147C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO875142A 1986-12-10 1987-12-09 Fremgangsmaate for fremstilling av en vaksine mot hepatittb NO171147C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617265A FR2608052B1 (fr) 1986-12-10 1986-12-10 Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu

Publications (4)

Publication Number Publication Date
NO875142D0 NO875142D0 (no) 1987-12-09
NO875142L NO875142L (no) 1988-06-13
NO171147B NO171147B (no) 1992-10-26
NO171147C true NO171147C (no) 1993-02-03

Family

ID=9341743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875142A NO171147C (no) 1986-12-10 1987-12-09 Fremgangsmaate for fremstilling av en vaksine mot hepatittb

Country Status (11)

Country Link
EP (1) EP0273811B1 (no)
JP (1) JPS63215639A (no)
KR (1) KR880007732A (no)
AT (1) ATE109353T1 (no)
CA (1) CA1306689C (no)
DE (1) DE3750330T2 (no)
DK (1) DK645687A (no)
FR (1) FR2608052B1 (no)
IL (1) IL84729A (no)
NO (1) NO171147C (no)
PT (1) PT86321B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073604A (zh) * 1991-12-01 1993-06-30 高真南 制备高免疫原性乙型肝炎疫苗的方法
AU3269793A (en) * 1991-12-27 1993-07-28 Gensci Limited Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Also Published As

Publication number Publication date
FR2608052B1 (fr) 1990-04-13
IL84729A0 (en) 1988-05-31
PT86321B (pt) 1990-11-07
JPS63215639A (ja) 1988-09-08
DE3750330T2 (de) 1994-11-17
DK645687A (da) 1988-06-11
DE3750330D1 (de) 1994-09-08
NO171147B (no) 1992-10-26
EP0273811A2 (fr) 1988-07-06
CA1306689C (en) 1992-08-25
PT86321A (fr) 1988-01-01
ATE109353T1 (de) 1994-08-15
FR2608052A1 (fr) 1988-06-17
NO875142L (no) 1988-06-13
EP0273811B1 (fr) 1994-08-03
KR880007732A (ko) 1988-08-29
NO875142D0 (no) 1987-12-09
EP0273811A3 (en) 1988-08-03
IL84729A (en) 1993-02-21
DK645687D0 (da) 1987-12-09

Similar Documents

Publication Publication Date Title
DE3280186D1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
EP0584348A4 (en) Genetic vaccine for immunodeficiency viruses
MA21911A1 (fr) Procede pour produire une grande proteine de surface modifiee du virus de l'hepatite b .
ATE59409T1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
AU571128B2 (en) Expression of immunologically reactive aids viral protein
AU2865084A (en) Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
NO171147C (no) Fremgangsmaate for fremstilling av en vaksine mot hepatittb
EP0198299A3 (en) A process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
AU4817885A (en) Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
GB2065473A (en) Process for producing hepatitis b vaccine
DE69324645D1 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
EP0255242A3 (en) Oncornavirus vaccines
EP0205625A1 (en) Hepatitis b virus vaccine and process for its preparation
Gerin et al. Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
PT72045B (en) Process for preparing vaccines for swine protection
ATE53235T1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
Leboulleux et al. Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
JPH0762033B2 (ja) B型肝炎ワクチン
KR950703054A (ko) A형 간염 비루스 백신(hepatitis a virus vaccine)
BR9705324C1 (pt) Método para produção de hbsag purificado para preparação de vacina e vacina recombinante contra a hepatite do tipo b